ClinicalTrials.Veeva

Menu

Tumor Microenvironment in Patients With Localized Osteosarcoma Treated With Mifamurtide: a Translational Study (Micros)

I

Istituto Ortopedico Rizzoli

Status

Completed

Conditions

Localized Osteosarcoma

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

International, multicenter retrospecitve biological study

Full description

International, multicenter retrospecitve biological study that will analyze the tumor micro environment in biological archival samples of patients, who were treated with chemotherapy +/- mifamurtide according the protocols for primary localized osteosarcoma (ISG-OS2 and GEIS-33)

Enrollment

80 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patients with primary localized osteosarcoma who received chemotherapy +/- mifamurtide according to ISG-OS2/GEIS-33 trials,
  2. Paraffin-embedded tissue tumor (FFPE) blocks from archive available to perform the biological analysis
  3. Written informed consent prior to any study-specific analysis and/or data collection

Exclusion criteria

1) Patients with diagnosis different from osteosarcoma

-

Trial design

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Emanuela Palmerini, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems